Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma
Open Access
- 1 November 2002
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 2 (5), 377-386
- https://doi.org/10.1016/s1535-6108(02)00179-4
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- The intrinsic ability of AFAP-110 to alter actin filament integrity is linked with its ability to also activate cellular tyrosine kinasesOncogene, 2001
- Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoterGenes & Development, 2001
- Expression of P27KIP1 is prognostic and independent ofMYCN amplification in human neuroblastomaInternational Journal of Cancer, 2001
- p190 RhoGAP is the principal Src substrate in brain and regulates axon outgrowth, guidance and fasciculationNature Cell Biology, 2001
- A PKC-η/Fyn-Dependent Pathway Leading to Keratinocyte Growth Arrest and DifferentiationMolecular Cell, 2000
- Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable eventsThe EMBO Journal, 2000
- Tyrosine Phosphorylation and Src Family Kinases Control Keratinocyte Cell–Cell AdhesionThe Journal of cell biology, 1998
- The current contribution of molecular factors to risk estimation in neuroblastoma patientsEuropean Journal Of Cancer, 1997
- fyn tyrosine kinase is involved in keratinocyte differentiation control.Genes & Development, 1995
- Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease StageScience, 1984